(Q34824876)

4 August 2017

1 reference

title

Evolving strategies for the use of combination therapy in hypertension (English)

1 reference

4 August 2017

Alan H Gradman

1

1 reference

PubMed ID

12217251

4 August 2017

Celso Acevedo

series ordinal

2

1 reference

4 August 2017

1 October 2002

1 reference

Current Hypertension Reports

4 August 2017

1 reference

4 August 2017

4

1 reference

4 August 2017

343-349

1 reference

4 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-002-0062-x

4 August 2017

0 references

cites work

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

12 December 2020

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Diuretic therapy for hypertension and the risk of primary cardiac arrest

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

1 reference

12 December 2020

Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals

1 reference

12 December 2020

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

10.1007/S11906-002-0062-X

Identifiers

DOI

1 reference

PubMed ID

12217251

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12217251